SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, today announced it will present three posters at ...

Detailed price information for Nkgen Biotech Inc (NKGN-Q) from The Globe and Mail including charting and trades.

At the 2024 Educational Research and Innovations in Clinical and Health Sciences (ENRICH) Week poster session, Hunter “Caroline” Davies secured first place in the innovation category for her poster, ...

SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer ...

SOTIO Biotech, a clinical-stage immuno-oncology company owned by PPF Group, today announced it will present three posters at the 2024 Society for Immunotherapy of Cancer Meeting taking place November ...

Nemuna Ceesay will direct industry presentations of the new musical ROSIE at Open Jar Studios, featuring Debbie Gravitte, ...

First presentation of ANV700, a targeted IL-21 employing proximity activated potentiation of cytokine signaling -- New mechanistic data provide ...

Ten presentations at ESGCT 2024 detail the therapeutic potential and applicability of the company’s platform in rare neurometabolic diseases and ...

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announces that ...

TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...

(NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...